Genovis

Genovis is a Lund-based biotech tools company that develops and sells unique enzymes for the characterization and analysis of antibody-based drugs. Its products are used by virtually all major global pharmaceutical and biotech companies during drug development. Listed on Nasdaq Stockholm, Genovis reported SEK 129 million in revenue for 2025 (17% growth) with strong profitability and cash generation. The company acquired Sequrna AB in 2025 to expand into RNA analytics and employs approximately 50 people.